Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Drug Makers Pin High Hopes on Biologics to Recover Investments on Psoriasis Treatment Market, More Tailored Treatments to Shape Future Avenue - TMR

This image opens in the lightbox

News provided by

Transparency Market Research

08 Sep, 2020, 15:30 GMT

Share this article

Share toX

Share this article

Share toX

- Appetite of personalized treatments high in North America and Asia, Robust Product Pipelines to Help Psoriasis Treatment Market to Clock CAGR of ~11 During 2019 – 2027

- Established Players Commit Sizable Research Funding to Accelerate Product Launches, While Getting Into Strategic Collaborations Help Them Unveil Novel Drug Classes Faster in Treatment Of Moderate-to-Severe Cases

ALBANY, N.Y., Sept. 8, 2020 /PRNewswire/ -- Drug pipelines are continuously expanding in psoriasis treatment market, with biologics fast becoming accessible in emerging markets. The need for potential, targeted treatments in patients with moderate to severe cases triggers a spirit of innovations. Personalized treatment as a part of newer modalities is thus a huge avenue for stakeholders in the psoriasis treatment market.

Of all the drug classes, interleukin inhibitors segment accounts for a high market share. A growing number of tailored therapies approved by FDA in recent years have shaped the evolution.

Clocking a CAGR of ~11% from 2019 to 2027, psoriasis treatment market is expected to witness new avenues on the back of research on psoriasis pathogenesis.

Request for Analysis of COVID-19 Impact on Psoriasis Treatment Market– https://www.transparencymarketresearch.com/covid19.php

Key Findings of Psoriasis Treatment Market Report

  • Of all the drug classes, interleukin inhibitors accounted for a high market share and will continue to gather traction
  • Of the various key routes of treatment in the market, parenteral held the leading share in 2018
  • Of all the key distribution channels, retail pharmacies held the major market share in 2018
  • Geographically, North America is the leading segment in psoriasis treatment market
  • Asia Pacific psoriasis market is expected to rise at promising growth rate during 2019 – 2027
  • Latin America and the Middle East & Africa are expected to rise at remarkable pace during assessment period

Explore 200 pages of top-notch research, incisive insights, and detailed country-level projections on Psoriasis Treatment Market (Drug Class: TNF Inhibitors, Interleukin Inhibitors, Vitamin D Analogs, Corticosteroids, and Others; Route of Administration: Oral, Parenteral, and Topical; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027 at https://www.transparencymarketresearch.com/report-toc/17960

Psoriasis Treatment Market: Key Driving Factors and Promising Avenues

  • Drug makers aimed at strengthening their positions in psoriasis treatment market are increasingly leaning on delivering value-based medicine to reduce the prevalence of psoriasis. The average worldwide prevalence is around 2%.
  • Over the years, psoriasis treatment market has seen research and investments in targeted therapies.
  • A better understanding of pathophysiology of psoriasis and skin biology is helping drug makers to come out with potent biologics and biosimilars, thus boosting the market.
  • Growing use of predictive biomarkers has helped improve the incidence rate, thereby boosting demand for psoriasis treatment.
  • Regulatory bodies, such as the U.S. FDA, are promoting the constant development of biologics and newer modalities. New modalities focus on managing more number of symptoms.
  • Growing presence of comorbidities in patients is opening new demand potential in the market. A case in point is the strong likelihood of patients to develop arthritis, especially in population of the U.S.

Request Brochure of Psoriasis Treatment Market Report - https://www.transparencymarketresearch.com/brochure.php

Psoriasis Treatment Market: Key Impediments to Growth and Competitive Landscape

The competitive landscape in the global psoriasis treatment market is abuzz with the approval of new drug classes, notably in developed countries. Aspiring players are unlocking revenue streams in biological therapies that target specific cytokines. Some companies are seeing attractive opportunities in parenteral delivery modes.

Top stakeholders will garner revenue gains by leveraging the synergies of strategic collaborations.

Some of the top players in the psoriasis treatment market are Johnson & Johnson, AstraZeneca plc., Pfizer, Merck & Co., Novartis AG, and Amgen, Inc.

Purchase the Psoriasis Treatment Market Report - https://www.transparencymarketresearch.com/checkout.php

Psoriasis Treatment Market: Regional Landscape

The U.S. and Canada have been seeing substantial sales of psoriasis drugs in retail pharmacies. The North America market as a whole is highly lucrative with vast appetite for the uptake of biologics, despite their being on higher side of prices. The remarkable effectiveness of these as a part of other tailored therapies has lent the regional market high growth momentum.

On the other hand, Asia Pacific is emerging as a highly lucrative regional market and is projected to rise at marked CAGR during 2019 – 2027. Strides being made by the pharmaceutical sector in the regions are helping drive the rapid generation of opportunities for drug makers.

Browse More Press Release - https://www.transparencymarketresearch.com/press-releases.htm

The Psoriasis Treatment Market can be segmented as follows:

Drug Class

  • TNF Inhibitors
  • Interleukin Inhibitors
  • Vitamin D Analogs
  • Corticosteroids

Route of Administration

  • Oral
  • Parenteral
  • Topical

Distribution Chanel

  • Hospital Pharmacies
  • Retail Pharmacies

Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

TNF Inhibitors Market: Expansion of the global TNF inhibitors market is driven by strong research & development and increasing awareness regarding usage of TNF inhibitors for the treatment of various rheumatic conditions during the forecast period. In terms of revenue, the global TNF inhibitors market was valued at US$ 40,369.9 Mn in 2017 and is projected to reach US$ 53,745.37 MN by 2026. It is expected to expand at a CAGR of 2.54% from 2018 to 2026.

Interleukin Inhibitors Market: Increase in the prevalence of chronic inflammatory diseases such as arthritis, psoriasis, and asthma is a major factor fuelling the global interleukin inhibitors market. In addition to this, increase in FDA approvals for novel drugs and therapies for chronic inflammatory disease treatment is further boosting the market.

Vitamin D Testing Market: Analysts of the vitamin D testing landscape have a positive outlook for market growth during the forecast period of 2019-2027. The vitamin D testing market is estimated to rise at a CAGR of ~6%. North America and Europe dominate the global market share in the vitamin D testing landscape, whereas, Asia Pacific has high growth potential in the coming years.

Browse Our Latest Reports - https://www.transparencymarketresearch.com/latest.htm

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Browse More Upcoming Reports by Transparency Market Research: https://www.transparencymarketresearch.com/upcoming.htm

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com 
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/psoriasis-treatment-market.htm 
Website: https://www.transparencymarketresearch.com/

Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg

Modal title

Also from this source

Ultra-high Purity Anhydrous Hydrogen Chloride (HCl) Gas Market to Reach USD 5.7 Billion by 2031, Expanding at a CAGR of 5.4% | TMR Report

Ultra-high Purity Anhydrous Hydrogen Chloride (HCl) Gas Market to Reach USD 5.7 Billion by 2031, Expanding at a CAGR of 5.4% | TMR Report

Over the last year, several companies have announced new semiconductor fabrication sites, especially in the U.S., India, and Europe. These...

Silicon Metal Market Size Projected to Expand to USD 10.7 Billion by 2031 Exhibiting 5.1% CAGR: Transparency Market Research, Inc.

Silicon Metal Market Size Projected to Expand to USD 10.7 Billion by 2031 Exhibiting 5.1% CAGR: Transparency Market Research, Inc.

The market was valued at US$ 6.9 billion in 2022. The Silicon Metal Market Growth is estimated to reach US$ 10.7 billion by the end of 2031,...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.